Tinnitus is a complex auditory perceptual disorder often accompanied by neuroinflammatory responses and metabolic abnormalities. Increasing evidence suggests that persistent oxidative stress, together with its interactions with immune regulation and energy metabolism, contributes to the pathophysiology of tinnitus....
No actionable change for current clinical practice; findings are discovery-stage and require substantial validation before informing tinnitus drug development or treatment protocols.
Identifying druggable molecular targets through genomic analysis could accelerate tinnitus pharmacotherapy research, an area with no FDA-approved treatments to date.
- 01Multi-omics analysis links oxidative stress pathways to tinnitus pathology.
- 02Neuroinflammatory and metabolic mechanisms are highlighted as key contributors.
- 03Specific druggable molecular targets for tinnitus are identified computationally.
- 04No existing FDA-approved pharmacological treatment for tinnitus exists, making this a significant research gap.
- 05Findings are discovery-stage and require experimental and clinical validation.
Oxidative stress-related pathways are associated with tinnitus based on integrative genomic and multi-omics analyses.
studypartially supportedNeuroinflammatory and metabolic mechanisms contribute to tinnitus pathology.
studypartially supportedSpecific druggable molecular targets for tinnitus have been identified through multi-omics approaches.
studyunclear- PMID
- 42131830
- DOI
- 10.3389/fneur.2026.1775859.
- Journal
- Frontiers in Neurology
- Publication type
- research_article
- Evidence level
- 2b
- Population
- Genomic and multi-omics datasets related to tinnitus (human genetic data)
- Intervention
- Integrative genomic and multi-omics pathway analysis
Primary outcomes
Identification of oxidative stress-related pathways associated with tinnitus; Identification of druggable molecular targets; Characterization of neuroinflammatory and metabolic mechanisms in tinnitus